These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25188790)

  • 1. Cell-based approach for treatment of corneal endothelial dysfunction.
    Okumura N; Kinoshita S; Koizumi N
    Cornea; 2014 Nov; 33 Suppl 11():S37-41. PubMed ID: 25188790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving therapies for Fuchs' endothelial dystrophy.
    Soh YQ; Peh GS; Mehta JS
    Regen Med; 2018 Jan; 13(1):97-115. PubMed ID: 29360003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current development of alternative treatments for endothelial decompensation: Cell-based therapy.
    Rodríguez-Fernández S; Piñeiro-Ramil M; Castro-Viñuelas R; Sanjurjo-Rodríguez C; Álvarez-Portela M; Fuentes-Boquete IM; Rendal-Vázquez E; M Díaz-Prado S
    Exp Eye Res; 2021 Jun; 207():108560. PubMed ID: 33811914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and Feasibility Assessment of a New Vehicle for Cell-Based Therapy for Treating Corneal Endothelial Dysfunction.
    Okumura N; Kakutani K; Inoue R; Matsumoto D; Shimada T; Nakahara M; Kiyanagi Y; Itoh T; Koizumi N
    PLoS One; 2016; 11(6):e0158427. PubMed ID: 27355373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pressure and corneal biomechanics in Fuchs' endothelial dystrophy and after posterior lamellar keratoplasty.
    Clemmensen K; Hjortdal J
    Acta Ophthalmol; 2014 Jun; 92(4):350-4. PubMed ID: 23607620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focus on cell therapy to treat corneal endothelial diseases.
    Faye PA; Poumeaud F; Chazelas P; Duchesne M; Rassat M; Miressi F; Lia AS; Sturtz F; Robert PY; Favreau F; Benayoun Y
    Exp Eye Res; 2021 Mar; 204():108462. PubMed ID: 33493477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of corneal endothelialization and corneal clearance after descemet membrane endothelial keratoplasty for fuchs endothelial dystrophy.
    Dirisamer M; Dapena I; Ham L; van Dijk K; Oganes O; Frank LE; van der Wees J; Melles GR
    Am J Ophthalmol; 2011 Oct; 152(4):543-555.e1. PubMed ID: 21726849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of keratoplasty: cell-based therapy, regenerative medicine, bioengineering keratoplasty, gene therapy.
    Mehta JS; Kocaba V; Soh YQ
    Curr Opin Ophthalmol; 2019 Jul; 30(4):286-291. PubMed ID: 31045881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior corneal aberrations after Descemet's stripping endothelial keratoplasty for Fuchs' endothelial dystrophy.
    Patel SV; Baratz KH; Maguire LJ; Hodge DO; McLaren JW
    Ophthalmology; 2012 Aug; 119(8):1522-9. PubMed ID: 22480739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye drops.
    Koizumi N; Okumura N; Ueno M; Kinoshita S
    Cornea; 2014 Nov; 33 Suppl 11():S25-31. PubMed ID: 25289721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo confocal microscopy of Fuchs endothelial dystrophy before and after endothelial keratoplasty.
    Patel SV; McLaren JW
    JAMA Ophthalmol; 2013 May; 131(5):611-8. PubMed ID: 23471204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous corneal clearance despite graft detachment in descemet membrane endothelial keratoplasty.
    Balachandran C; Ham L; Verschoor CA; Ong TS; van der Wees J; Melles GR
    Am J Ophthalmol; 2009 Aug; 148(2):227-234.e1. PubMed ID: 19442962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous corneal clearance despite graft removal in Descemet stripping endothelial keratoplasty in Fuchs endothelial dystrophy.
    Ziaei M; Barsam A; Mearza AA
    Cornea; 2013 Jul; 32(7):e164-6. PubMed ID: 23594769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary clinical results of Descemet membrane endothelial keratoplasty.
    Melles GR; Ong TS; Ververs B; van der Wees J
    Am J Ophthalmol; 2008 Feb; 145(2):222-227. PubMed ID: 18061137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descemet's stripping with endothelial keratoplasty for special Fuchs' endothelial dystrophy in phakic eyes.
    Huang T; Luo Y; Wang Y; Hu A; Gao N
    Ophthalmic Res; 2011; 46(1):44-9. PubMed ID: 21212708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue.
    Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Tsuchiya H; Hamuro J; Kinoshita S
    Am J Pathol; 2012 Jul; 181(1):268-77. PubMed ID: 22704232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental models of corneal endothelial cell therapy and translational challenges to clinical practice.
    Rolev K; Coussons P; King L; Rajan M
    Exp Eye Res; 2019 Nov; 188():107794. PubMed ID: 31518569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models.
    Koizumi N; Okumura N; Kinoshita S
    Exp Eye Res; 2012 Feb; 95(1):60-7. PubMed ID: 22067130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentacam characterization of corneas with Fuchs dystrophy treated with Descemet membrane endothelial keratoplasty.
    Kwon RO; Price MO; Price FW; Ambrósio R; Belin MW
    J Refract Surg; 2010 Dec; 26(12):972-9. PubMed ID: 20166622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface markers of functional phenotypic corneal endothelial cells.
    Okumura N; Hirano H; Numata R; Nakahara M; Ueno M; Hamuro J; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(11):7610-8. PubMed ID: 25389199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.